Results 171 to 180 of about 5,194 (193)
Some of the next articles are maybe not open access.

Disorder: Tyrosinemia type 1

2020
Patricia Jones   +2 more
openaire   +1 more source

Type 1 Tyrosinemia with Hypophosphatemic Rickets; a Case Report

2014
Background: Tyrosinemia type 1 is an autosomal recessive metabolic disorder, which typically affects liver and kidneys. It is caused by a defect in fumarylacetoacetate hydrolase or fumarylacetoacetase (FAH) enzyme, the final enzyme in the tyrosine degradation pathway.
Eshraghi, Peyman   +2 more
openaire   +1 more source

Tyrosinemia type 1: an overview of nursing care.

Pediatric nursing, 2014
Tyrosinemia type 1 (TT1) is an inherited metabolic disease that can be fatal when not detected early by newborn screening. In the past, children with TT1 had a poor prognosis due to organ failure and neurologic crisis during infancy. Recent improvements in newborn screening have changed the prognosis of affected children. Measurement of succinylacetone
openaire   +1 more source

Hereditary tyrosinemia type 1

Current Opinion in Gastroenterology, 1991
openaire   +1 more source

A patient with urinary succinylacetone‐negative hereditary tyrosinemia type 1

Pediatrics International, 2023
Jun Mori   +6 more
openaire   +2 more sources

Maleic acid is a biomarker for maleylacetoacetate isomerase deficiency; implications for newborn screening of tyrosinemia type 1

Journal of Inherited Metabolic Disease, 2023
Allysa Dijkstra, Rebecca Heiner-Fokkema
exaly  

S3069 Lifesaving but Tiresome Treatment for Tyrosinemia Type 1

American Journal of Gastroenterology, 2022
Moon Ryu   +3 more
openaire   +1 more source

Neurologic Crises in Hereditary Tyrosinemia

New England Journal of Medicine, 1990
Grant A Mitchell, Serge Melancon
exaly  

Home - About - Disclaimer - Privacy